role prostacyclin cardiovascular response thromboxane a2 
thromboxane tx a2 vasoconstrictor platelet agonist aspirin affords cardioprotection inhibition txa2 formation platelet cyclooxygenase cox- prostacyclin pgi2 vasodilator inhibits platelet function show injury-induced vascular proliferation platelet activation enhanced mice genetically deficient pgi2 receptor ip depressed mice genetically deficient txa2 receptor tp treated tp antagonist augmented response vascular injury abolished mice deficient receptors thus pgi2 modulates platelet-vascular interactions vivo specifically limits response txa2 interplay may help explain adverse cardiovascular effects associated selective cox- inhibitors unlike aspirin nonsteroidal anti-inflammatory drugs nsaids inhibit pgi2 txa2 
